logo
Little Remedies honey cough syrup recalled nationwide: What parents need to know

Little Remedies honey cough syrup recalled nationwide: What parents need to know

Yahoo7 hours ago

As parents, we do everything we can to keep our children safe—especially when they're sick. That's why a new nationwide recall of a popular over-the-counter children's cough medicine is raising serious concern.
Medtech Products Inc. has voluntarily recalled several lots of Little Remedies® Honey Cough Syrup after the U.S. Food and Drug Administration (FDA) found the presence of Bacillus cereus, a harmful bacteria that can cause foodborne illness—and in severe cases, even death.
The recalled syrup, a go-to for many parents looking for natural relief for their child's cough, was sold online and in stores across the U.S. between December 2022 and June 2025. While no serious injuries have been reported as of now, the company is urging families to stop using the affected products immediately.
Here's what you need to know to keep your little ones safe.
The recall affects Little Remedies® Honey Cough Syrup, sold in 4 FL OZ (118 mL) amber bottles, commonly found in pharmacies, grocery stores, and online retailers. The syrup is marketed as a gentle, natural remedy made with honey to soothe coughs in children — but the recent discovery of Bacillus cereus contamination has made certain lots unsafe for use.
According to the official FDA notice, the bacteria was detected in certain lots, prompting a recall due to concerns about shelf stability and potential health risks. While no other Little Remedies® products are affected, all lots of this particular syrup still within the expiration date have been included in the recall out of an abundance of caution.
Here are the affected lot numbers and expiration dates:
Lot 0039 – Expires 11/2025
Lot 0545 – Expires 01/2026
Lot 0640 – Expires 02/2026
Lot 0450 – Expires 05/2026
Lot 1198 – Expires 12/2026
Each recalled bottle has a UPC of 7-56184-10737-9 and should have the lot number printed on both the label and the bottom of the box.
If you have one of these in your medicine cabinet, read on for what steps to take next.
Bacillus cereus is a type of bacteria that can cause foodborne illness when ingested — especially when it grows in products that are no longer shelf-stable. While it may sound unfamiliar to many parents, the symptoms it causes are unfortunately very recognizable.
There are two common types of illness linked to B. cereus:
The first appears 1 to 6 hours after exposure and typically causes nausea, vomiting, and stomach cramps.
The second appears 8 to 16 hours after exposure, with symptoms including diarrhea and abdominal pain. In some cases, the diarrhea may be severe and watery.
In most healthy children, these symptoms may pass on their own. However, exposure to high levels of can lead to more serious illness — and in rare cases, it can be fatal.
If your child has consumed the recalled syrup and shows any of these symptoms, it's important to contact your pediatrician or seek medical attention right away. When in doubt, trust your instincts — you know your child best.
Related: Here's how I'm preparing for my kids' sick days this year
If you have a bottle of Little Remedies® Honey Cough Syrup at home, the first step is to stop using it immediately — even if your child has taken it without any symptoms. Check both the UPC (7-56184-10737-9) and the lot number, which can be found on the bottle label and the bottom of the box.
Here's what to do next:
If your child has taken the syrup and is experiencing nausea, vomiting, diarrhea, or stomach pain, call your pediatrician right away.
If your child seems fine, monitor them closely for symptoms for up to 24 hours.
To request a refund or report an issue, you can contact Medtech directly:
Call: (800) 754-8853 (Monday–Friday, 8:30 a.m. to 5:30 p.m. ET)
Email: medicalaffairs@prestigebrands.com
Website: www.prestigebrands.com/contact
If you or your healthcare provider believe your child experienced a reaction to the product, you can also report it through the FDA's MedWatch program at www.fda.gov/medwatch.
It's always okay to ask questions, trust your instincts, and reach out for guidance when your child's health is involved.
Related: Target recalls baby food over lead concerns—here's what parents should do
Recalls like this can feel unsettling, especially when they involve products we trust. But by staying informed and taking quick action, you're doing exactly what your child needs.
No serious injuries have been reported, and the recall is precautionary — but it's always better to be safe. If you have concerns, talk to your pediatrician. When it comes to your child's health, caution is care.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Former Steelers return to Pittsburgh to raise money for cancer research
Former Steelers return to Pittsburgh to raise money for cancer research

CBS News

time32 minutes ago

  • CBS News

Former Steelers return to Pittsburgh to raise money for cancer research

Former Steelers return to Pittsburgh to raise money for cancer research Former Steelers return to Pittsburgh to raise money for cancer research Former Steelers return to Pittsburgh to raise money for cancer research Two former Steelers were on hand Friday night to help raise money for cancer research at UPMC's Hillman Center. For the past nine years at the Dr. Stanley M. Marks Blood Cancer Research Fund Dinner, the James Conner Courage Award has been given to a blood cancer survivor. Conner was diagnosed with Hodgkin's lymphoma 10 years ago when he played at the University of Pittsburgh, before he became a running back for the Pittsburgh Steelers. Conner, a former patient of Dr. Marks, was the first recipient of the award before it was named after him. All but one of the recipients were at the 10th annual event Friday, held at Acrisure Stadium. They are the faces of courage. "It's just like getting up every day and living your life, you know, not letting anything stop you," said Meghan Milligan, this year's Courage Award recipient. The 35-year-old has been diagnosed with cancer three times and is currently receiving treatment for Hodgkin's Lymphoma. "Just taking it day by day," she said. She's done it all while competing in several marathons and is the only recipient who is still battling cancer. Conner said courage in cancer was all about battling. "It's been a long road, man, truthfully, a lot of hard work went into it, you just have to learn how to be a fighter," Conner said. "Cancer is kind of a mental fight, so just got to fight hard." Another former Steeler, Merril Hoge, was a special guest at the event. "How I look at courage is when you face something you think you can't face, and you win," Hoge said. He said he was there for a simple reason. "Because 22 years ago, there was a chance I wasn't going to be here," Hoge said. He, too, is a 20-year lymphoma survivor who was a patient of Dr. Marks. Hoge explained that the fundraising for Dr. Marks and others 40 years ago is the reason he's still alive. "My focus has been treating and curing blood cancer, and so the research behind it is so critical," Marks said. The money raised at the dinner will go to UPMC's Hillman Center, where Marks told KDKA-TV it will be used as startup funds for young researchers who would otherwise struggle to find funding. In the years since the fund started, they have raised almost $20 million, Marks said. "I'm humbled, I'm honored really," Dr. Marks said of the large crowd at the event. "I would have never imagined that it would be as successful for this many years." It all benefits people like Milligan, who says it is important to stay positive in the face of obstacles. "Obviously, you have the hard days, but you just go about life, live it to your fullest, even if you're going through a hard time, just enjoy it and live the most you can," Milligan said. KDKA-TV's Bob Pompeani emceed the dinner Friday night, as he has for most of the last decade. He was also recognized with an award for all the time he's spent volunteering.

This Under-the-Radar Healthcare Stock Could Be a Solid Income Play
This Under-the-Radar Healthcare Stock Could Be a Solid Income Play

Yahoo

time34 minutes ago

  • Yahoo

This Under-the-Radar Healthcare Stock Could Be a Solid Income Play

CVS Health Corporation (NYSE:CVS) is one of the best dividend stocks for a bear market. Even during economic downturns, people continue to rely on medications, essential consumer products, and affordable local healthcare. CVS Health Corporation (NYSE:CVS) serves as a convenient healthcare and retail destination within communities. A row of shelves in a retail pharmacy, demonstrating the variety of drugs and over-the-counter products. The company's overall business remains solid, thanks to its diversified operations and multiple sources of revenue. In recent years, it has expanded its presence in primary care and launched a subsidiary called Cordavis to focus on developing and marketing biosimilar drugs. Its broad reach across communities and wide range of services are key advantages. Lately, higher Medicare usage and increased post-pandemic healthcare costs have impacted the company's revenue and earnings growth. However, CVS Health Corporation (NYSE:CVS) remains profitable and maintains a solid cash position. In the most recent quarter, it reported $4.6 billion in operating cash flow. Looking ahead to 2025, the company has raised its full-year operating cash flow forecast from around $6.5 billion to approximately $7.0 billion. In addition, CVS Health Corporation (NYSE:CVS) appears to have significant room to grow its dividend. With a cash payout ratio of just 30%, even doubling that figure would still leave it within a sustainable range. Due to this strong cash generation, CVS Health Corporation (NYSE:CVS) has maintained its payouts since 1997. Currently, it offers a quarterly dividend of $0.665 per share and has a dividend yield of 3.96%, as of June 17. While we acknowledge the potential of CVS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store